| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Icosavax, Inc. | Former Director | Common Stock | 0 | $0 | $15.29 | 19 Feb 2024 | By Qiming U.S. Healthcare Fund II, L.P. |
| Icosavax, Inc. | Former Director | Common Stock | 0 | $0 | $15.29 | 19 Feb 2024 | Direct |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | By Qiming U.S. Healthcare Fund III,L.P. |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | By Qiming U.S. Healthcare Fund II,L.P. |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | By Qiming U.S. Healthcare Fund I,L.P. |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | Direct |
| Tourmaline Bio, Inc. | Director | Stock Option (Right to Buy) | 16.8K | 04 Jun 2025 | Direct | ||
| Icosavax, Inc. | Former Director | Stock Option (Right to Buy) | 0 | 19 Feb 2024 | Direct | ||
| Tourmaline Bio, Inc. | Director | Employee Stock Option (Right to Buy) | 0 | 28 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRML | Tourmaline Bio, Inc. | 28 Oct 2025 | 7 | $0 | 4 | Director | 28 Oct 2025, 18:30 |
| TRML | Tourmaline Bio, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:30 |
| TRML | Tourmaline Bio, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:03 |
| ICVX | Icosavax, Inc. | 19 Feb 2024 | 4 | $0 | 4 | Former Director | 20 Feb 2024, 19:38 |
| TRML | Tourmaline Bio, Inc. | 29 Jan 2024 | 1 | $3.25M | 4 | Director | 31 Jan 2024, 16:26 |
| TALS | Tourmaline Bio, Inc. | 19 Oct 2023 | 4 | $0 | 4 | Director | 23 Oct 2023, 20:26 |
| TALS | Talaris Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 18:59 |
| ICVX | Icosavax, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 20:46 |
| ICVX | Icosavax, Inc. | 10 Jun 2022 | 2 | $0 | 4 | Director | 14 Jun 2022, 16:12 |
| TALS | Talaris Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 18:20 |
| ICVX | Icosavax, Inc. | 01 Apr 2022 | 1 | $300K | 4 | Director | 05 Apr 2022, 16:10 |